Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification

BMC Cardiovascular Disorders

Volumn 14, Issue , 2014, Pages

  Rodriguez, Karien J ^a   Piechura, Laura M ^a   Porras, Ana M ^a   Masters, Kristyn S ^a  

^a University of Wisconsin Madison   (United States)

Author keywords

Calcific aortic valve disease; Collagen; Extracellular matrix; Valvular interstitial cells

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; OSTEOCALCIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; AORTA VALVE STENOSIS; APOPTOSIS; ARTICLE; BIOCHEMICAL COMPOSITION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC REGULATION; IN VITRO STUDY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEPLETION; PROTEIN EXPRESSION; VALVULAR INTERSTITIAL CELL;

ANIMALS; AORTIC VALVE; APOPTOSIS; BIOLOGICAL MARKERS; CALCINOSIS; CELL PROLIFERATION; COLLAGEN; DNA REPLICATION; GENE EXPRESSION REGULATION; HEART VALVE DISEASES; PHENOTYPE; SWINE; TIME FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 84896726788     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-29     Document Type: Article

References (39)

1. Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O'Brien KD, Schoen FJ, Towler DA, Yoganathan AP, Otto CM. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group. Executive summary: calcific aortic valve disease-2011 update. Circulation 2011, 124(16):1783-1791. 10.1161/CIRCULATIONAHA.110.006767, 3306614, 22007101.
2. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: from bench to the bedside-emerging clinical and cellular concepts. Heart 2003, 89(7):801-805. 10.1136/heart.89.7.801, 1767746, 12807865.
3. Mohler ER. Mechanisms of aortic valve calcification. Am J Cardiol 2004, 94(11):1396-1402. A1396, 10.1016/j.amjcard.2004.08.013, 15566910.
4. Hinton RB, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 2006, 98(11):1431-1438. 10.1161/01.RES.0000224114.65109.4e, 16645142.
5. Rodriguez KJ, Piechura LM, Masters KS. Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environments. Matrix Biol 2011, 30(1):70-82. 10.1016/j.matbio.2010.09.001, 3021089, 20884350.
6. Benton JA, Kern HB, Anseth KS. Substrate properties influence calcification in valvular interstitial cell culture. J Heart Valve Dis 2008, 17(6):689-699. 2735090, 19137803.
7. Rodriguez KJ, Masters KS. Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J Biomed Mater Res A 2009, 90(4):1043-1053.
8. Eriksen HA, Satta J, Risteli J, Veijola M, Vare P, Soini Y. Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis. Atherosclerosis 2006, 189(1):91-98. 10.1016/j.atherosclerosis.2005.11.034, 16405893.
9. Chen JH, Simmons CA. Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res 2011, 108(12):1510-1524. 10.1161/CIRCRESAHA.110.234237, 21659654.
10. Cushing MC, Liao JT, Jaeggli MP, Anseth KS. Material-based regulation of the myofibroblast phenotype. Biomaterials 2007, 28(23):3378-3387. 10.1016/j.biomaterials.2007.04.005, 17475322.
11. Grande-Allen KJ, Griffin BP, Ratliff NB, Cosgrove DM, Vesely I. Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol 2003, 42(2):271. 10.1016/S0735-1097(03)00626-0, 12875763.
12. Bashey RI, Torii S, Angrist A. Age-related collagen and elastin content of human heart valves. J Gerontol 1967, 22(2):203-208. 10.1093/geronj/22.2.203, 6022112.
13. Taylor PM. Biological matrices and bionanotechnology. Philos Trans R Soc Lond B Biol Sci 2007, 362(1484):1313-1320. 10.1098/rstb.2007.2117, 2440397, 17581810.
14. Latif N, Sarathchandra P, Taylor PM, Antoniw J, Yacoub MH. Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis 2005, 14(2):218-227.
15. Scott M, Vesely I. Aortic valve cusp microstructure: the role of elastin. Ann Thorac Surg 1995, 60(2 Suppl):S391-394.
16. Schoen FJ. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis 1997, 6(1):1-6.
17. Rajamannan NM, Bonow RO, Rahimtoola SH. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 2007, 4(5):254-262. 10.1038/ncpcardio0827, 17457349.
18. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001, 104(21):2525. 10.1161/hc4601.099489, 11714645.
19. Edep ME, Shirani J, Wolf P, Brown DL. Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 2000, 9(5):281-286. 10.1016/S1054-8807(00)00043-0, 11064275.
20. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999, 274(31):21491-21494. 10.1074/jbc.274.31.21491, 10419448.
21. Fondard O, Detaint D, Iung B, Choqueux C, Adle-Biassette H, Jarraya M, Hvass U, Couetil JP, Henin D, Michel JB. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J 2005, 26(13):1333-1341. 10.1093/eurheartj/ehi248, 15827062.
22. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961, 93:440-447. 10.1016/0003-9861(61)90291-0, 13786180.
23. Goll DE, Bray RW, Hoekstra WG. Age-associated changes in muscle composition. The isolation and properties of a collagenous residue from bovine muscle a. J Food Sci 1963, 28(5):503-509.
24. Barbosa I, Garcia S, Barbier-Chassefiere V, Caruelle JP, Martelly I, Papy-Garcia D. Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 2003, 13(9):647-653. 10.1093/glycob/cwg082, 12773478.
25. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kolb SA, Grunenfelder J, Zund G, Turina MI. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002, 106(12 Suppl 1):I143-150.
26. Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004, 329(1):77-84. 10.1016/j.ab.2004.02.002, 15136169.
27. Taylor PM, Cass AEG, Yacoub MH. Extracellular matrix scaffolds for tissue engineering heart valves. Prog Pediatr Cardiol 2006, 21(2):219-225.
28. Taylor PM, Allen SP, Dreger SA, Yacoub MH. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J Heart Valve Dis 2002, 11(3):298-306. discussion 306-297.
29. Jian B, Narula N, Li QY, Mohler ER, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003, 75(2):457-465. discussion 465-456, 10.1016/S0003-4975(02)04312-6, 12607654.
30. Kaden JJ, Dempfle CE, Grobholz R, Tran HT, Kilic R, Sarikoc A, Brueckmann M, Vahl C, Hagl S, Haase KK, Borggrefe M. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003, 170(2):205. 10.1016/S0021-9150(03)00284-3, 14612199.
31. Gu X, Masters KS. Role of the MAPK/ERK pathway in valvular interstitial cell calcification. Am J Physiol Heart Circ Physiol 2009, 296(6):H1748-1757. 10.1152/ajpheart.00099.2009, 19363136.
32. Liu AC, Gotlieb AI. Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells. Am J Pathol 2008, 173(5):1275-1285. 10.2353/ajpath.2008.080365, 2570119, 18832581.
33. Jian B, Jones PL, Li Q, Mohler ER, Schoen FJ, Levy RJ. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol 2001, 159(1):321-327. 10.1016/S0002-9440(10)61698-7, 1850407, 11438479.
34. Balachandran K, Bakay MA, Connolly JM, Zhang X, Yoganathan AP, Levy RJ. Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness. Ann Thorac Surg 2011, 92(1):147-153. 10.1016/j.athoracsur.2011.03.084, 3184405, 21718840.
35. Merryman WD, Lukoff HD, Long RA, Engelmayr GC, Hopkins RA, Sacks MS. Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol 2007, 16(5):268-276. 10.1016/j.carpath.2007.03.006, 2094120, 17868877.
36. Balachandran K, Konduri S, Sucosky P, Jo H, Yoganathan AP. An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch. Ann Biomed Eng 2006, 34(11):1655-1665.
37. Sun L, Rajamannan NM, Sucosky P. Design and validation of a novel bioreactor to subject aortic valve leaflets to side-specific shear stress. Ann Biomed Eng 2011, 39(8):2174-2185. 10.1007/s10439-011-0305-6, 3899241, 21455792.
38. Gandaglia A, Bagno A, Naso F, Spina M, Gerosa G. Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. Eur J Cardiothorac Surg 2011, 39(4):523-531. 10.1016/j.ejcts.2010.07.030, 21163670.
39. Durst CA, Jane Grande-Allen K. Design and physical characterization of a synchronous multivalve aortic valve culture system. Ann Biomed Eng 2010, 38(2):319-325. 10.1007/s10439-009-9846-3, 19953323.